AII
LGND icon

AGF Investments Inc’s Ligand Pharmaceuticals LGND Stock Holding History

AGF Investments Inc’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-42
Closed -$2K – 791
2020
Q3 		$2K Buy
+42
New +$2.87K ﹤0.01% 785

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

AGF Investments Inc's LGND Position: Q4 2020 in Review

AGF Investments Inc sold out of Ligand Pharmaceuticals (LGND) in Q4 2020, closing a stake of 42 shares — an estimated $2K sold.

AGF Investments Inc first reported a position in LGND in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • AGF Investments Inc reported no remaining Ligand Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • AGF Investments Inc sold 42 Ligand Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • AGF Investments Inc first reported a position in Ligand Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • AGF Investments Inc's Ligand Pharmaceuticals position peaked at $2K in Q3 2020.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on AGF Investments Inc's 13F filing for Q4 2020, filed 8 Feb 2021.